The following statement, recently published in the Congressional Record, was submitted by Gabriel Levitt on October 30, 2019, on behalf of PharmacyChecker and Prescription Justice, to the Committee on Ways and Means of the U.S. House of Representatives 116th Congress pertaining to a hearing entitled: “Investing In The U.S. Health System By Lowering Drug Prices, Reducing, Out-of-Pocket Costs and Improving the Medicare Benefit”.
“Investing In The U.S.
Health System By Lowering Drug Prices, Reducing, Out-of-Pocket Costs and
Improving the Medicare Benefit”
October 29, 2019
Co-founder and President, PharmacyChecker.com, 333 Mamaroneck Avenue, White Plains, NY 10605, 718-554-3067, firstname.lastname@example.org
Founder and President, Prescription Justice, 3309 Robbins Road,
#412, Springfield, Illinois 62704, email@example.com
Our company, PharmacyChecker.com verifies online pharmacies,
and compares drug prices among those accredited in our online pharmacy Verification
Program. Consumers, Americans and worldwide, access our website for free. Our
website has received about 30 million visitors since we launched our virtual
doors in 2003. Our niche is comparative pricing and the proper credentialing of
international online pharmacies, which process prescription drug orders filled
by licensed pharmacies in several countries, require valid prescriptions, and
do not ship controlled drugs into the U.S. We also provide information about
discounted U.S. pharmacy prices and patient assistance programs. The information we provide helps people make
the best decisions for themselves and their families when struggling with the
cost of prescription drugs.[i]
(more…)Tagged with: Congressional House Ways and Means Committee
Millions of people are dying because they are not getting the healthcare they need and that includes prescription drugs. New research has made a slam dunk case for why international online pharmacy options are needed urgently. We can’t allow drug companies to continue fooling the public about drug importation.
Poll survey announced yesterday found that 34 million Americans know
someone who died because they could not afford medical treatments. That doesn’t
mean prescription drug affordability specifically was the cause. In fact, the
Gallup Poll lacks details about what kinds of medical treatments were too
expensive. However, the poll identifies that a rising percentage of Americans
are reporting going without prescriptions because of cost: from 18.9% in
January to 22.9% in September of 2019. That would be about 58 million Americans
who say they did not fill a prescription in the past 12 months because of cost.
Since pharmacies in other countries charge much lower prices, and properly
credentialed international online pharmacies make those drugs available, the
veracity of the title of this blog post is undeniable.
(more…)Tagged with: Congressional House Ways and Means Committee, Dr. Nicky J. Mehtani, Gallup Poll
A report (“A Painful Pill to Swallow: U.S. vs. International Prescription Drug Prices”) was released this week by the Congressional House Ways and Means Committee, showing that brand name drug prices are much lower – by about 75% on average – in other high-income countries. Who knew? Well, our analysis from this past summer showed that the average savings on popular brand drugs filled through online orders with Canadian pharmacies was 75%. When including pharmacies in other countries, the savings jumped to 90%. Those include pharmacies located in middle income countries, such as Turkey. For the record, these are comparisons among PharmacyChecker-accredited online pharmacies.
The committee’s report looked at prices of 79 brand name
drugs in the following countries: Australia, Canada (specifically Ontario),
Denmark, France, Germany, Japan, Netherlands, Portugal, Sweden, Switzerland,
and the United Kingdom. I highly recommend reading this report if you want to
learn about international drug price differentials and better understand how
Americans are getting ripped off.
(more…)Tagged with: Congressional House Ways and Means Committee, External reference pricing